PCRCR complex is essential for invasion of human erythrocytes by <i>Plasmodium falciparum</i>

dc.contributor.authorScally, Stephen W.en
dc.contributor.authorTriglia, Tonyen
dc.contributor.authorEvelyn, Cindyen
dc.contributor.authorSeager, Benjamin A.en
dc.contributor.authorPasternak, Michałen
dc.contributor.authorLim, Pailene S.en
dc.contributor.authorHealer, Julieen
dc.contributor.authorGeoghegan, Niall D.en
dc.contributor.authorAdair, Amyen
dc.contributor.authorTham, Wai Hongen
dc.contributor.authorDagley, Laura F.en
dc.contributor.authorRogers, Kelly L.en
dc.contributor.authorCowman, Alan F.en
dc.date.accessioned2025-05-31T07:29:10Z
dc.date.available2025-05-31T07:29:10Z
dc.date.issued2022-11-17en
dc.description.abstractThe most severe form of malaria is caused by Plasmodium falciparum. These parasites invade human erythrocytes, and an essential step in this process involves the ligand PfRh5, which forms a complex with cysteine-rich protective antigen (CyRPA) and PfRh5-interacting protein (PfRipr) (RCR complex) and binds basigin on the host cell. We identified a heteromeric disulfide-linked complex consisting of P. falciparum Plasmodium thrombospondin-related apical merozoite protein (PfPTRAMP) and P. falciparum cysteine-rich small secreted protein (PfCSS) and have shown that it binds RCR to form a pentameric complex, PCRCR. Using P. falciparum lines with conditional knockouts, invasion inhibitory nanobodies to both PfPTRAMP and PfCSS, and lattice light-sheet microscopy, we show that they are essential for merozoite invasion. The PCRCR complex functions to anchor the contact between merozoite and erythrocyte membranes brought together by strong parasite deformations. We solved the structure of nanobody–PfCSS complexes to identify an inhibitory epitope. Our results define the function of the PCRCR complex and identify invasion neutralizing epitopes providing a roadmap for structure-guided development of these proteins for a blood stage malaria vaccine.en
dc.description.sponsorshipWe thank Australian Red Cross Blood Service for blood, Walter and Eliza Hall Institute Monoclonal Laboratory for monoclonal antibodies, E. Knuepfer for CRISPR–Cas9 plasmids and M. Mlodzianoski for discussions related to analysis of PAM. Crystallization screening was undertaken at the CSIRO Collaborative Crystallisation Centre (www.csiro.au/C3), Melbourne, Australia. This research was undertaken in part using the MX2 beamline at the Australian Synchrotron, part of the Australian Nuclear Science and Technology Organisation, and made use of the Australian Cancer Research Foundation (ACRF) detector. This work was supported by the National Health and Medical Research Council of Australia (APP1194535 to A.F.C., APP1173049 to S.W.S.) and a Victorian State Government Operational Infrastructure Support grant (institutional grant). We thank Australian Red Cross Blood Service for blood, Walter and Eliza Hall Institute Monoclonal Laboratory for monoclonal antibodies, E. Knuepfer for CRISPR–Cas9 plasmids and M. Mlodzianoski for discussions related to analysis of PAM. Crystallization screening was undertaken at the CSIRO Collaborative Crystallisation Centre ( www.csiro.au/C3 ), Melbourne, Australia. This research was undertaken in part using the MX2 beamline at the Australian Synchrotron, part of the Australian Nuclear Science and Technology Organisation, and made use of the Australian Cancer Research Foundation (ACRF) detector. This work was supported by the National Health and Medical Research Council of Australia (APP1194535 to A.F.C., APP1173049 to S.W.S.) and a Victorian State Government Operational Infrastructure Support grant (institutional grant).en
dc.description.statusPeer-revieweden
dc.format.extent15en
dc.identifier.otherPubMed:36396942en
dc.identifier.scopus85142134933en
dc.identifier.urihttp://www.scopus.com/inward/record.url?scp=85142134933&partnerID=8YFLogxKen
dc.identifier.urihttps://hdl.handle.net/1885/733756187
dc.language.isoenen
dc.rightsPublisher Copyright: © 2022, The Author(s).en
dc.sourceNature Microbiologyen
dc.titlePCRCR complex is essential for invasion of human erythrocytes by <i>Plasmodium falciparum</i>en
dc.typeJournal articleen
dspace.entity.typePublicationen
local.bibliographicCitation.lastpage2053en
local.bibliographicCitation.startpage2039en
local.contributor.affiliationScally, Stephen W.; Walter and Eliza Hall Institute of Medical Researchen
local.contributor.affiliationTriglia, Tony; Walter and Eliza Hall Institute of Medical Researchen
local.contributor.affiliationEvelyn, Cindy; Walter and Eliza Hall Institute of Medical Researchen
local.contributor.affiliationSeager, Benjamin A.; Walter and Eliza Hall Institute of Medical Researchen
local.contributor.affiliationPasternak, Michał; Walter and Eliza Hall Institute of Medical Researchen
local.contributor.affiliationLim, Pailene S.; Walter and Eliza Hall Institute of Medical Researchen
local.contributor.affiliationHealer, Julie; Walter and Eliza Hall Institute of Medical Researchen
local.contributor.affiliationGeoghegan, Niall D.; Walter and Eliza Hall Institute of Medical Researchen
local.contributor.affiliationAdair, Amy; Walter and Eliza Hall Institute of Medical Researchen
local.contributor.affiliationTham, Wai Hong; Walter and Eliza Hall Institute of Medical Researchen
local.contributor.affiliationDagley, Laura F.; Walter and Eliza Hall Institute of Medical Researchen
local.contributor.affiliationRogers, Kelly L.; Walter and Eliza Hall Institute of Medical Researchen
local.contributor.affiliationCowman, Alan F.; Walter and Eliza Hall Institute of Medical Researchen
local.identifier.citationvolume7en
local.identifier.doi10.1038/s41564-022-01261-2en
local.identifier.purec1857c19-1112-43e9-b2b1-d447c7dac799en
local.identifier.urlhttps://www.scopus.com/pages/publications/85142134933en
local.type.statusPublisheden

Downloads